Iterum Therapeutics Plc (ITRM)

Iterum Therapeutics' (ITRM) “Buy” Rating Reiterated at HC Wainwright - Defense World

Defense World

What Kind Of Investors Own Most Of Iterum Therapeutics plc (NASDAQ:ITRM)? - Yahoo Movies UK

Yahoo Movies UK

Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Q1 2024 Iterum Therapeutics PLC Earnings Call Transcript - GuruFocus.com

GuruFocus.com

Earnings call: Iterum Therapeutics reports Q1 2024 financials, updates on Sulopenem - Investing.com UK

Investing.com UK

Akoya Biosciences Reports First Quarter 2024 Financial Results - Yahoo Canada Finance

Yahoo Canada Finance

IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study - Yahoo Canada Finance

Yahoo Canada Finance

Iterum Therapeutics Reports First Quarter 2024 Financial Results - 13.05.2024 - wallstreet:online

wallstreet:online

Iterum Therapeutics (ITRM) to Release Quarterly Earnings on Monday - Defense World

Defense World

Iterum Therapeutics Announces CMO Transition and Consultant Role - TipRanks.com - TipRanks

TipRanks

Infectious disease index continues decline despite positive news - BioWorld Online

BioWorld Online

What Kind Of Investors Own Most Of Iterum Therapeutics plc (NASDAQ:ITRM)? - Yahoo Movies UK

Yahoo Movies UK

Pile Foundation Construction Service Industry Research Study |Menard Soltraitement, Keller Group, Bauer Group - Motions Online

Motions Online

3D Modeling Software for Game Market Emerging Trends | Autodesk, Unity, Adobe - Motions Online

Motions Online

Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024 - EIN News

EIN News

What April's slowing job growth means for the Fed - Yahoo Canada Finance

Yahoo Canada Finance

Iterum Therapeutics (NASDAQ:ITRM) Stock Rating Reaffirmed by HC Wainwright - Defense World

Defense World

Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

GlobeNewswire Inc.

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer's Hemophilia B Gene ... - Pink Sheet

Pink Sheet

Iterum Therapeutics (NASDAQ:ITRM) vs. RedHill Biopharma (NASDAQ:RDHL) Head to Head Contrast - Defense World

Defense World

DIVIDEND 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share - Yahoo Canada Finance

Yahoo Canada Finance

Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

GlobeNewswire Inc.

Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat

GlobeNewswire Inc.

Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up

Zacks Investment Research

Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up - Yahoo Finance

Yahoo Finance

Sulopenem Etzadroxil/Probenecid Market Size and Share Analysis Across 7MM and Competitive Landscape by ... - openPR

openPR

BioWorld Infectious Disease Index closes 2023 down 43% - BioWorld Online

BioWorld Online

Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC - Yahoo Finance

Yahoo Finance

Iterum reports positive results from Phase III trial of oral sulopenem - Clinical Trials Arena

Clinical Trials Arena

Why Iterum Therapeutics Stock Is Trending Today - Iterum Therapeutics (NASDAQ:ITRM) - Benzinga

Benzinga

United States Movie Market Analysis Report 2024-2030: Emerging Trends for Different Genders, Age Groups, Screen ... - Yahoo Finance UK

Yahoo Finance UK

Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3

Benzinga

Gas prices fell at a faster pace in Canadian cities this week, but one Ont. city sees double-digit drop - Yahoo Canada Finance

Yahoo Canada Finance

Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89% - Yahoo Finance

Yahoo Finance

All You Need to Know About Iterum Therapeutics PLC (ITRM) Rating Upgrade to Strong Buy - Yahoo Finance

Yahoo Finance

Cotações de Ações Americanas: Bolsas ao vivo e últimas notícias - Money Times

Money Times

UTIs: Why did you have to go and make things so complicated? - Contemporary Obgyn

Contemporary Obgyn

Pyelonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - GlobalData

GlobalData

Noelle honoured at Institute of Directors presentation - The Echo Newspaper

The Echo Newspaper

Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players ... - GlobalData

GlobalData

As the world grows weary of COVID-19, so do infectious disease investors - BioWorld Online

BioWorld Online

63 Biggest Movers From Friday | Markets Insider - Markets Insider

Markets Insider

Cocrystal Pharmaceuticals Inc. (NASDAQ: COCP) Says Its COVID-19 Proteases Inhibitor CDI-45205 Effective Against ... - BP Journal

BP Journal

The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical ... - Markets Insider

Markets Insider

FDA approvals drop as regulatory activity continues to climb - BioWorld Online

BioWorld Online

Hot Biotech Penny Stocks To Buy? 3 to Watch Right Now - Penny Stocks

Penny Stocks

Iterum Therapeutics (ITRM): Delayed Review Of Its NDA For Sulopenem, Upside Still Exists - Seeking Alpha

Seeking Alpha

Eyenovia Stock (NASDAQ:EYEN), Quotes and News Summary - Benzinga

Benzinga